Results 201 to 210 of about 78,062 (255)
Reverse Takotsubo Syndrome Triggered by COVID-19-Associated Cytokine Storm: Unveiling a Novel Pattern of Myocardial Dysfunction in SARS-CoV-2 Infection. [PDF]
Am J Case RepBriones-Claudett KH +9 more
europepmc +1 more source
Myopericarditis in an emergency department patient presenting with chest pain and ECG changes: a case report. [PDF]
Egypt Heart JCoaxum L, McClean C, Theophanous R.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Joint Bone Spine, 2006
Colchicine is used chiefly in the treatment of gout but is also valuable in other inflammatory diseases such as familial Mediterranean fever (FMF). Three proteins play pivotal roles in colchicine pharmacokinetics: the colchicine receptor, tubulin, which governs the plasma elimination half-life of the drug; intestinal and hepatic CYP3A4, which is key to
Elisabeth, Niel, Jean-Michel, Scherrmann
openaire +2 more sources
Colchicine is used chiefly in the treatment of gout but is also valuable in other inflammatory diseases such as familial Mediterranean fever (FMF). Three proteins play pivotal roles in colchicine pharmacokinetics: the colchicine receptor, tubulin, which governs the plasma elimination half-life of the drug; intestinal and hepatic CYP3A4, which is key to
Elisabeth, Niel, Jean-Michel, Scherrmann
openaire +2 more sources
Annals of the New York Academy of Sciences, 2009
Purified from a Mediterranean plant nearly two centuries ago, colchicine has been discovered to inhibit many steps in the inflammatory process. The drug has good oral bioavailability and some enterohepatic recirculation, requiring dose adjustments for kidney disease and avoidance in liver disease. Toxicities are primarily gastrointestinal, hepatic, and
Anupama, Bhat +3 more
openaire +2 more sources
Purified from a Mediterranean plant nearly two centuries ago, colchicine has been discovered to inhibit many steps in the inflammatory process. The drug has good oral bioavailability and some enterohepatic recirculation, requiring dose adjustments for kidney disease and avoidance in liver disease. Toxicities are primarily gastrointestinal, hepatic, and
Anupama, Bhat +3 more
openaire +2 more sources
JCR: Journal of Clinical Rheumatology, 1996
Colchicine myopathy can complicate standard treatment of gout, especially in those patients with underlying renal insufficiency. The symptoms of this disorder are frequently insidious, and the diagnostic tests used in its evaluation are mostly nonspecific.
D S, Uri, M, Biavis
openaire +2 more sources
Colchicine myopathy can complicate standard treatment of gout, especially in those patients with underlying renal insufficiency. The symptoms of this disorder are frequently insidious, and the diagnostic tests used in its evaluation are mostly nonspecific.
D S, Uri, M, Biavis
openaire +2 more sources
Scandinavian Journal of Rheumatology, 1996
Colchicine myopathy typically presents as painless muscle weakness. This report describes a post renal-transplant patient who presented with pain in both extremities bilaterally that was refractory to narcotic analgesics. He had been on low dose daily colchicine for 7 years. Laboratory, EMG, and biopsy findings all supported the diagnosis of colchicine
openaire +2 more sources
Colchicine myopathy typically presents as painless muscle weakness. This report describes a post renal-transplant patient who presented with pain in both extremities bilaterally that was refractory to narcotic analgesics. He had been on low dose daily colchicine for 7 years. Laboratory, EMG, and biopsy findings all supported the diagnosis of colchicine
openaire +2 more sources